- Ananworanich J, Gorowara M, Avihingsanon A, van Heesch N, Kerr S, Khongpetch C, Uanithirat A, Hill A, Ruxrungtham K, and Burger D. Low-Dose RAL at 400 mg Once Daily Achieves Adequate Plasma Concentrations in HIV-1-infected Thai Patients. [Abstract # 649]
http://retroconference.org/2011/PDFs/649.pdf
http://f1000.com/posters/view/document/1089232 - Chokephaibulkit K, Prasitsuebsai W, Wittawatmongkol O, Gorowara M, Phongsamart W, Wongsabut J, Vanprapar N, Puthanakit T, Burger D, Ananworanich J on behalf of the HIV-NAT 113 Study Group. Pharmacokinetics of darunavir/ritonavir in Asian HIV-1 infected children aged ≥ 6 years. [Poster # 714]
http://www.retroconference.org/2011/PDFs/714.pdf
http://f1000.com/posters/view/document/1089316 - Crane M, Rajasuriar R, Avihingsanon A, Matthews G, Skinner N, Tangkitvanich P, Dore GJ, Visvanathan K, Ruxrungtham K, Lewin SR. LPS, immune activation and liver disease in HIV-HBV co-infection. [Poster # 937]
http://retroconference.org/2011/PDFs/937.pdf - Avihingsanon A, Praditpornsilpa K , Wongsabut J, Clark A, Kerr SJ, Ubolyam S, Phanuphak P, Ananworanich J, Hiransuthikul N, Ruxrungtham K and HIV-NAT 006 study team. Prevalence and prognostic factors of chronic kidney disease in HIV-infected patients, HIV-NAT 006 cohort, Thailand. [Poster # 843]
http://www.natap.org/2011/CROI/croi_70.htm
http://retroconference.org/2011/PDFs/843.pdf - Bunupuradah T, Chetchotisakd P, Ananworanich J, Munsakul W, Jirajariyavet S, Kantipong P, Prasithsirikul W, Sungkanuparph S, Bowonwatanuwong C, Klinbuayaem V, Hirschel B, Bhakeecheep S, Ruxrungtham K and HIV STAR study team. Second line lopinavir/ritonavir monotherapy was inferior to tenofovir/lamivudine/lopinavir/ritonavir in patients who failed NNRTI-regimen: HIV STAR study. [Poster # 584]
http://retroconference.org/2011/PDFs/584.pdf
http://f1000.com/posters/view/document/1089259 - Puthanakit T, Kerr S, Bunupuradah T, Aurpibul L, Taecharoenkul S, Sirisanthana V, Law M, and Ananworanich J. Slow accumulation of thymidine analog and etravirine-associated mutations in NNRTI treated children with virologic failure. [Poster # S-159]
http://www.retroconference.org/2011/PDFs/720.pdf
http://f1000.com/posters/view/document/1089264 - Klinklom A, Puthanakit T, Gorowara M, Phasomsap C, Kerr S, Sriheara C, Ananworanich J, Burger D, Ruxrungtham K and Pancharoen C. Low Dose of Lopinavir/ritonavir Achieves Adequate Pharmacokinetic Parameters in HIV-Infected Thai Children. [Abstract # S-119]
http://www.retroconference.org/2011/PDFs/709.pdf
http://f1000.com/posters/view/document/1089260
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Powered by 